Hereditary pancreatitis and pancreatic cancer — what a PRSS1 result actually means

Hereditary pancreatitis is an uncommon inherited condition in which the pancreas inflames itself, again and again, usually beginning in childhood, adolescence or early adult life rather than in later years. Attacks of acute pancreatitis recur over a long period, and the gland gradually scars into chronic pancreatitis. Most people reach a page like this one after a gastroenterologist has finally used the word “hereditary” about pain that has been happening for years, and the question underneath is almost always the same private one.

So let us answer it directly. When people search hereditary pancreatitis cancer risk, they want to know whether this diagnosis makes pancreatic cancer inevitable. It does not. What is true is that hereditary pancreatitis sits among the inherited conditions carrying the higher lifetime pancreatic cancer risk, and that the risk comes from the decades of inflammation and repair the gland goes through — not from the gene switching cancer on directly. It is the pancreatitis that is inherited. The cancer risk is a downstream consequence of it, and that distinction matters more than it sounds, because it is what makes part of the risk movable.

The genetics are unusually clean for an inherited-risk condition. Most families are traced to a gain-of-function change in PRSS1, the gene for cationic trypsinogen — the enzyme that is supposed to become active in the intestine and not inside the pancreas itself. The change lets that activation happen too readily within the gland, and inflammation follows. Inheritance is autosomal dominant, so a child of a carrier has a one-in-two chance of inheriting the change. Penetrance is incomplete: some carriers have attacks from childhood, and others go through life with few symptoms or none at all. Searches for PRSS1 pancreatic cancer tend to mix this classic pattern together with changes in SPINK1, CFTR and CTRC, which behave differently — more as modifiers of susceptibility, often in recessive or combined patterns, rather than as a straightforward dominant inheritance.

Two things are commonly confused with this, and they are worth separating before you read further. Familial pancreatic cancer means pancreatic cancer clustering in a family with no pancreatitis in the picture at all — a different question with a different answer. And ordinary chronic pancreatitis from alcohol or gallstone disease also carries a raised risk, explained in full on chronic pancreatitis and pancreatic cancer risk; that is the right page if nothing about your history looks inherited. For the disease itself — symptoms, tests, staging and treatment — start from our complete guide to pancreatic cancer. What follows stays on the inherited version alone.

• Pancreatitis that began in childhood, adolescence or early adult life and was never fully explained — no gallstones, no heavy alcohol use, no clear trigger.
• Repeated attacks over years, rather than one severe episode that settled and never came back.
• More than one blood relative with pancreatitis on the same side of the family. That pattern is behind most searches for familial pancreatitis cancer risk, and it is the single most useful thing to bring to a first appointment.
• A relative already known to carry a PRSS1 change, or already told they have hereditary pancreatitis. What that means for you is a counselling question before it is a testing question.
• Chronic pancreatitis diagnosed young, with the cancer question left hanging. The non-inherited version of that conversation is set out in chronic pancreatitis and pancreatic cancer risk.
• You already have a genetic result and want to know what follow-up is warranted — see screening for people at high risk of pancreatic cancer, which explains who is offered surveillance and how it is run.
• You smoke, or you used to. With this diagnosis that is not a lifestyle footnote. It is the main modifiable part of your risk, and it deserves a proper conversation rather than a leaflet.

1. 1

   A free 45-minute consultation, and a family tree drawn properly

   The first appointment is a conversation, not a triage. We take the pancreatitis history in detail — age at the first attack, how often since, what previous imaging showed — and map both sides of the family, because an inherited pattern only becomes visible once it is written down.

   In-house at CION
2. 2

   Genetic counselling before any test is sent

   Counselling comes first, so you understand in advance what a positive, a negative and an uncertain result would each mean — for you, and for the relatives who will hear about it next. A result nobody prepared you for is far harder to live with than one you chose.

   In-house at CION
3. 3

   The consequences treated, not just the risk labelled

   Enzyme replacement and nutrition support for a gland that no longer digests properly, management of type 3c diabetes, pain care, and psycho-oncology for the part nobody mentions — carrying a family risk. This is most of what improves daily life, and all of it is delivered by CION.

   In-house at CION
4. 4

   Imaging ordered and reported, with its limits stated

   Pancreatic-protocol CT, MRI with MRCP, CA 19-9 and routine bloods are ordered and reported at CION. We will also tell you plainly that a scarred, calcified pancreas is harder to read than a normal one, which is exactly why surveillance belongs with an experienced service — see screening for people at high risk of pancreatic cancer.

   In-house at CION
5. 5

   Endoscopy and surgery, arranged with partner centres

   Endoscopic ultrasound and EUS-FNA biopsy, ERCP and biliary stenting, coeliac plexus block for pain, staging laparoscopy, PET-CT, and all pancreatic surgery — including total pancreatectomy, which is occasionally raised in hereditary pancreatitis — are coordinated with specialist HPB, gastroenterology and endoscopy partner centres, and may be billed there. If a diagnosis is ever made, the pathway from that point is set out in pancreatic cancer treatment in Hyderabad.

   Coordinated with specialist partner centres

You will find lifetime risk figures for hereditary pancreatitis quoted online, and we deliberately quote none of them here. Every published figure comes from a limited number of studied families, followed over different periods, using different definitions of who counts as affected. Those figures are useful to researchers comparing groups. They are close to useless as a statement about one person sitting in a clinic room, and reading one is far more likely to frighten you than to change anything you do. What is worth saying instead is the direction of travel: the risk is real, it is higher than in most other inherited situations, it accumulates across a lifetime rather than arriving on a date, and it is not a certainty for anybody.

Against that, here is the part that genuinely moves. Tobacco is the factor most consistently reported to raise the cancer risk further in hereditary pancreatitis and to bring it forward in life, and unlike the gene, it is entirely yours to change. Stopping is not a token gesture on this page; it is the largest single lever anyone with this diagnosis has. Alcohol matters as well, less as a cancer factor in its own right than as a reliable way of provoking further attacks in a gland that is already inflamed. Keeping the pancreas as quiet as possible — through enzyme support, sensible nutrition and good blood-sugar control — is worth doing for how you feel week to week, quite apart from anything it may do over decades.

The question of who else in the family should be tested comes up at every one of these appointments, and it has a settled answer. An adult relative who wants to know can be tested after counselling, because the result may change how their own symptoms are interpreted and whether specialist follow-up is offered at all. Predictive testing of a child with no symptoms is usually deferred until they are old enough to decide for themselves, since knowing earlier rarely changes anything that would be done for them. A child who is already having unexplained attacks is a different situation entirely: there, testing can supply the explanation and end years of being told that nothing is wrong.

Finally, surveillance. Structured imaging follow-up is considered for people at high inherited risk, and hereditary pancreatitis is one of the situations specialists weigh it for — but it is a specialist decision made in an experienced service, not a scan to book yourself each year, and not screening in the sense the word is usually used. The honest version of who is offered it, what it involves and what it can and cannot find is set out in screening for people at high risk of pancreatic cancer. If you are here because a relative is already in treatment rather than because of your own history, the pathway they are on is described in pancreatic cancer treatment in Hyderabad, and the wider picture in our complete pancreatic cancer guide.

Medical disclaimer: This page explains hereditary pancreatitis and its relationship to pancreatic cancer risk in general terms, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma and on genetic and familial high-risk assessment. It is general information and not a risk calculation for any individual; your own risk, testing and follow-up should be discussed with a doctor who knows your history. Consultation and family-history assessment, genetic counselling, pancreatic-protocol CT, MRI/MRCP, CA 19-9 and routine bloods, medical and radiation oncology, nutrition and enzyme (PERT) support, type 3c diabetes and pain management, psycho-oncology and survivorship care are delivered by CION. Endoscopic ultrasound and EUS-FNA biopsy, ERCP and biliary stenting, coeliac plexus block, staging laparoscopy, PET-CT and all pancreatic surgery, including total pancreatectomy, are coordinated with specialist HPB, gastroenterology and endoscopy partner centres and may be billed there.